Home > Boards > US OTC > Delisted > Ocata Therapeutics Inc. (fka OCAT)

I think the company had it right keeping

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
homeslice10 Member Profile
 
Followed By 33
Posts 3,035
Boards Moderated 0
Alias Born 01/24/12
160x600 placeholder
Top Company News of the Day
FedEx Corp., which has thrived during the coronavirus pandemic, on Thursday reported that "exceptional" growth in U.S. and international shipping propelled it to a record fourth quarter.
Nike 4Q Sales Nearly Double
Nigerian President Travels to U.K. for Medical Follow-Up
Hogs Futures Fall as U.S. Inventories Rise
Wheat Declines as Weather Turns Wetter
Front Month Nymex RBOB Gasoline Rose 0.62% to Settle at $2.2809 -- Data Talk
Front Month Nymex Natural Gas Rose 2.55% to Settle at $3.4180 -- Data Talk
Snapchat Users Gain Access to Universal Music Group's Library of Music
4D Molecular Shares Hit 52-Week Low After Roche Ends Collaboration Agreement
Pieris Pharmaceuticals Shares Rise 19% After Getting Orphan Drug Status
CAC-40 Index Ends 1.22% Higher at 6631.15 -- Data Talk
FTSE 100 Index Ends 0.51% Higher at 7109.97 -- Data Talk
STOXX Europe 50 Index Ends 0.67% Higher at 3542.88 -- Data Talk
DAX Ends 0.86% Higher at 15589.23 -- Data Talk
EURO STOXX 50 Index Ends 1.14% Higher at 4122.43 -- Data Talk
STOXX Europe 600 Index Ends 0.87% Higher at 457.04 -- Data Talk
FTSE 100 Closes Higher as Bank of England Keeps Bank Rate Unchanged
Biogen Worst Performer in S&P 500 and Nasdaq 100 So Far Today -- Data Talk
Manufacturing Activity in Central U.S. Expands Strongly in June -- Kansas City Fed
Merck Names Michael Klobuchar Chief Strategy Officer
Personal Income Seen Down 2.7% in May -- Data Week Ahead
Mortgage Rates Climb Above 3%, Freddie Mac Says
Gilead Sciences Sees Positive Results From Trial for Hepatitis Treatment
Prothena to Get $80 Million After Bristol Myers Exercises Option for Alzheimer's Treatment
Belgium Business Confidence Reaches All-Time High in June
4D Molecular Therapeutics Gets Termination Notice From Roche
FTSE 100 Builds on Gains After Bank of England Decision
homeslice10   Wednesday, 08/05/15 10:31:17 AM
Re: lasers post# 87033
Post # of 92944 
I think the company had it right keeping them separately trialed. Sure they can save money if new management can combine into one study but it's already cost an extra year waiting on fda. So whatever money we save by combining we could have made by selling treatment in 6 more months

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences